Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Nexalin Therapy for the Treatment of Depressive Symptoms

NCT00774813

Conditions: Anxiety Disorders, Behavior, Behavioral Symptoms, +12 more
Locations: Leningrad Regional Center of Addiction Saint Petersburg, Vsevolozhsky District, Russia

St. Petersburg City Center of Neuroses Saint Petersburg, Russia

View Trial Details

Completed

Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas

NCT00085904

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: GSK Investigational Site Indianapolis, Indiana, United States

GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy

NCT00222443

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Oklahoma University Health Sciences Center-Jimmy Everest Center Oklahoma City, Oklahoma, United States

View Trial Details

Completed

A Study of Patients With AIDS Syndrome

NCT00001120

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chromosome Aberrations, +35 more
Locations: Willow Clinic Menlo Park, California, United States

San Francisco Gen Hosp San Francisco, California, United States

Marin County Specialty Clinic San Rafael, California, United States

San Mateo AIDS Program / Stanford Univ Stanford, California, United States

View all 23 locations

View Trial Details

Completed

Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00290004

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: USC Norris Cancer Hospital Los Angeles, California, United States

Scripps Cancer Center San Diego, California, United States

Northwestern University Chicago, Illinois, United States

The Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma

NCT00347971

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: University of California, Los Angeles Los Angeles, California, United States

View Trial Details

Completed

Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL)

NCT00346684

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: University of Cologne Cologne, Germany

View Trial Details

Completed

Liposomal Anthracyclin in the Treatment of Elderly ALL

NCT00600977

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Regional university hospital Angers, France

View Trial Details

Completed

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

NCT00196885

Conditions: Atrophy, Body Weight, Body Weight Changes, +32 more
Locations: German Cancer Research Center, D020 Heidelberg, Baden-Wurttemberg, Germany

View Trial Details

Completed

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

NCT00017680

Conditions: Amyloidosis, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations: Herbert Irving Comprehensive Cancer Center New York, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions